Perioperative Use of Continuous Glucose Monitoring for Scheduled Cesarean Deliveries (PERUSE)

Starting soon

Conditions studied: Dysglycemia

In brief

This prospective pilot study is exploratory in nature and is designed to evaluate the validity of continuous glucose monitor (CGM) use for perioperative glucose surveillance during scheduled Cesarean delivery for nondiabetic patients. Primary objective is characterization of perioperative glucose trends during elective Cesarean delivery in patients without diabetes and exploratory analyses will describe perioperative glucose patterns captured by CGM. Secondary objective is to examine rates of and associations with post-operative complications, including surgical site infections.

Key facts

Study ID

NCT07671599

Run by

Icahn School of Medicine at Mount Sinai

People needed

150

Starts

2026-09-01

Expected to finish

2028-05-01

Last updated by the study team

2026-06-26

Who can join

Age: 18 and older, up to 50. Sex: any. Healthy volunteers: not accepted.

You may qualify if…

• singleton pregnancy
• no prior diagnosis of diabetes (gestational included)
• scheduled term cesarean delivery in Mount Sinai Health System
• aged 18-50 years

You may not qualify if…

• preexisting diabetes mellitus
• diagnosis of gestational diabetes mellitus (GDM) in the current pregnancy, based on standard prenatal screening
• known endocrine disorder affecting glucose metabolism (such as Cushing syndrome, poorly controlled thyroid disorder, etc.)
• use of antenatal steroids within the two weeks prior to delivery

Where it is running

• Icahn School of Medicine at Mount Sinai — New York, New York, United States

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.